The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy: A Randomized Controlled Trial
Abstract
CONTEXT: Hyperhomocysteinemia is frequently observed in patients with diabetic nephropathy. B-vitamin therapy (folic acid, vitamin B(6), and vitamin B(12)) has been shown to lower the plasma concentration of homocysteine. OBJECTIVE: To determine whether B-vitamin therapy can slow progression of diabetic nephropathy and prevent vascular complications. DESIGN, SETTING, AND PARTICIPANTS: A multicenter, randomized, double-blind, placebo-controlled trial (Diabetic Intervention with Vitamins to Improve Nephropathy [DIVINe]) at 5 university medical centers in Canada conducted between May 2001 and July 2007 of 238 participants who had type 1 or 2 diabetes and a clinical diagnosis of diabetic nephropathy. INTERVENTION: Single tablet of B vitamins containing folic acid (2.5 mg/d), vitamin B(6) (25 mg/d), and vitamin B(12) (1 mg/d), or matching placebo. MAIN OUTCOME MEASURES: Change in radionuclide glomerular filtration rate (GFR) between baseline and 36 months. Secondary outcomes were dialysis and a composite of myocardial infarction, stroke, revascularization, and all-cause mortality. Plasma total homocysteine was also measured. RESULTS: The mean (SD) follow-up during the trial was 31.9 (14.4) months. At 36 months, radionuclide GFR decreased by a mean (SE) of 16.5 (1.7) mL/min/1.73 m(2) in the B-vitamin group compared with 10.7 (1.7) mL/min/1.73 m(2) in the placebo group (mean difference, -5.8; 95% confidence interval [CI], -10.6 to -1.1; P = .02). There was no difference in requirement of dialysis (hazard ratio [HR], 1.1; 95% CI, 0.4-2.6; P = .88). The composite outcome occurred more often in the B-vitamin group (HR, 2.0; 95% CI, 1.0-4.0; P = .04). Plasma total homocysteine decreased by a mean (SE) of 2.2 (0.4) micromol/L at 36 months in the B-vitamin group compared with a mean (SE) increase of 2.6 (0.4) micromol/L in the placebo group (mean difference, -4.8; 95% CI, -6.1 to -3.7; P < .001, in favor of B vitamins). CONCLUSION: Among patients with diabetic nephropathy, high doses of B vitamins compared with placebo resulted in a greater decrease in GFR and an increase in vascular events. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN41332305.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Self-citationHomocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Self-citationLimitations of creatinine as a filtration marker in glomerulopathic patients
Shemesh, O., Golbetz, H., Kriss, J. P., & Myers, B. D. (1985) · Kidney International · doi:10.1038/ki.1985.205 · Cited by 1,227
Nephropathy in Patients with Type 2 Diabetes
Remuzzi, G., Schieppati, A., & Ruggenenti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 587
Albert, C. M., Cook, N. R., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., & Manson, J. E. (2008) · JAMA · doi:10.1001/jama.299.17.2027 · Cited by 511
Refsum, H., Nurk, E., David Smith, A., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygård, O., & Vollset, S. E. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1731s · Cited by 493
Chambers, J. C., McGregor, A., Jean-Marie, J., Obeid, O. A., & Kooner, J. S. (1999) · Circulation · doi:10.1161/01.cir.99.9.1156 · Cited by 428
Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12
Ebbing, M. (2009) · JAMA · doi:10.1001/jama.2009.1622 · Cited by 428
Ebbing, M., Bleie, Ø., Ueland, P. M., Nordrehaug, J. E., Nilsen, D. W., Vollset, S. E., Refsum, H., Ringdal Pedersen, E. K., & Nygård, O. (2008) · JAMA · doi:10.1001/jama.300.7.795 · Cited by 411
Poddar, R., Sivasubramanian, N., DiBello, P. M., Robinson, K., & Jacobsen, D. W. (2001) · Circulation · doi:10.1161/01.cir.103.22.2717 · Cited by 344
Bostom, A. G., Silbershatz, H., Rosenberg, I. H., Selhub, J., D'Agostino, R. B., Wolf, P. A., Jacques, P. F., & Wilson, P. W. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1077 · Cited by 325
Homocysteine Trials — Clear Outcomes for Complex Reasons
Loscalzo, J. (2006) · New England Journal of Medicine · doi:10.1056/nejme068060 · Cited by 300
Chambers, J. C., Ueland, P. M., Obeid, O. A., Wrigley, J., Refsum, H., & Kooner, J. S. (2000) · Circulation · doi:10.1161/01.cir.102.20.2479 · Cited by 245
Tissue Plasminogen Activator Binding to the Annexin II Tail Domain
Hajjar, K. A., Mauri, L., Jacovina, A. T., Zhong, F., Mirza, U. A., Padovan, J. C., & Chait, B. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9987 · Cited by 236
Homocysteine-lowering therapy: a role in stroke prevention?
Spence, J. D. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70219-3 · Cited by 220
Self-citationThe burden of diabetes and its complications: Trends and implications for intervention
Chaturvedi, N. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.019 · Cited by 168
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Dayal, S., & Lentz, S. R. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.166421 · Cited by 124
Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes
Looker, H. C., Fagot‐Campagna, A., Gunter, E. W., Pfeiffer, C. M., Narayan, K. M. V., Knowler, W. C., & Hanson, R. L. (2003) · Diabetologia · doi:10.1007/s00125-003-1104-x · Cited by 111
Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years' experience
Parving, H., Rossing, P. R., Hommel, E. E., & Smidt, U. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90162-0 · Cited by 96
Hyperhomocysteinemia and arteriosclerosis: historical perspectives
McCully, K. S. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.172 · Cited by 92
Palmer, A. J., Valentine, W. J., Chen, R., Mehin, N., Gabriel, S., Bregman, B., & Rodby, R. A. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn082 · Cited by 87
Homocysteine Binds to Human Plasma Fibronectin and Inhibits Its Interaction With Fibrin
Majors, A. K., Sengupta, S., Willard, B. B., Kinter, M. T., Pyeritz, R. E., & Jacobsen, D. W. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000023899.93940.7c · Cited by 83
Longitudinal Ultrasound Evaluation of Carotid Atherosclerosis in One, Two and Three Dimensions
Mallett, C. L., House, A. A., Spence, J. D., Fenster, A., & Párraga, G. (2008) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2008.09.008 · Cited by 51
Self-citationAccurate measurement of impaired glomerular filtration using single-dose oral cimetidine
Zaltzman, J. S., Whiteside, C. I., Cattran, D., Lopez, F. M., & Logan, A. G. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90160-2 · Cited by 42
Self-citationFolic Acid-Based Intervention in Non-ST Elevation Acute Coronary Syndromes
Imasa, M. S. B., Gomez, N. T., & Nevado, J. B. (2009) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492309102494 · Cited by 32
Epidemiology of Homocysteine as a Risk Factor in Diabetes
Becker‐Commissaris, A., Smulders, Y. M., van Guldener, C., & Stehouwer, C. D. A. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322294434 · Cited by 19
Urquhart, B. L., Freeman, D. J., Spence, J. D., & House, A. A. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007303767 · Cited by 16
Self-citation
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797
Metadata
- Authors
- House, A. A., Eliasziw, M., Cattran, D. C., Churchill, D. N., Oliver, M. J., Fine, A., Dresser, G. K., & Spence, J. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-04-28
- Volume
- 303
- Issue
- 16
- Pages
- 1603
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2048144298
- Cited by
- 308
- References
- 33
- FWCI
- 20.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.